This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Artemis Diagnostics Announces Company Name Change To Lightpoint Medical, And Appointment Of David Ford To The Board Of Directors

RICKMANSWORTH, England, January 25, 2013 /PRNewswire/ --

Artemis Diagnostics Ltd, a developer of innovative imaging technologies for cancer surgery, announced today that the company has changed its name to Lightpoint Medical Ltd. The name change reflects the company's focus on the medical device sector.

The company also announced the appointment of David Ford to its Board of Directors. Mr Ford has more than 20 years' experience in the medical device industry including 12 years at board level. Formerly the Executive Director of BSI Group, he was responsible for the worldwide Healthcare and Testing activity for the British Standards Institution. During David's tenure, BSI became the leading certification and accreditation body to the global healthcare industry incorporating two notified bodies in support of the European Medical Devices Directive. David is currently a Non-Executive Director at TrusTECH, an innovation gateway within the NHS. He has represented the United Kingdom at the World Health Organization, the FDA and the European Commission in developing policy for medical devices and medical device regulation. David was trained at St. Mary's Hospital Medical School, London and at Brunel University, and holds an MBA from INSEAD.

Dr David Tuch, CEO of Lightpoint Medical, commented "We are delighted to welcome David Ford to our Board of Directors. David's extensive experience in medical device regulations, marketing, and sales will bring significant value to Lightpoint Medical. We look forward to his contributions to the company as we advance our imaging technology to the market."

About Lightpoint Medical

Lightpoint Medical is an early-stage medical device company seeking to improve health outcomes for cancer patients through image-guided surgery. The company's molecular imaging technology, based on Cerenkov Luminescence Imaging, has the potential to detect cancer in real-time during surgery, providing more accurate cancer treatment while sparing healthy tissue.

For more information contact David Tuch on +44-(0)7725-832-539, info@lightpointmedical.com or visit  http://www.lightpointmedical.com.

SOURCE Lightpoint Medical

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,077.51 -2.63 -0.01%
S&P 500 2,114.27 -3.42 -0.16%
NASDAQ 5,070.4930 -21.5920 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs